4894 — Cuorips Share News
0.000.00%
Table: Cuorips -2026/27 group forecast
Table: Cuorips -2025/26 parent results
Table: Cuorips -2025/26 group results
Japanese government panel endorses Sumitomo Pharma's iPS-derived treatment for Parkinson's (updated)
Japan government panel endorses Sumitomo Pharma's iPS-derived treatment for Parkinson's, newspaper says
Table: Cuorips - 9-MTH group results
Table: Cuorips - 6-MTH group results
Table: Cuorips -Q1 group results
Table: Cuorips -2024/25 group results
Table: Cuorips - 9-MTH group results
Table: Cuorips - 6-MTH group results
Table: Cuorips -Q1 group results
Brief: Nikkei Says Osaka University-Affiliated Cuorips Developed Cardiac Tissue Sheet
Table: Cuorips -2023/24 group results
Table: Cuorips - 9-MTH group results
Table: Cuorips - 6-MTH parent results
Table: Cuorips - Q1 parent results